Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Oncolytics Biotech, Inc.
(NQ:
ONCY
)
2.720
USD
UNCHANGED
Streaming Delayed Price
/ Updated:
2:06 PM EDT, May 22, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Stories about Oncolytics Biotech, Inc.
< Previous
1
2
3
4
5
Next >
Wedbush Starts Oncolytics Biotech (ONCY) at Outperform; New Class of Cancer Therapy Emerges
April 12, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6424951 for the full story.
Read More
from
StreetInsider.com News Articles
4 Cash-Rich Biotechs Smart Money Loves
March 29, 2011
Institutional buyers have been adding shares of these four biotechs, each with big stockpiles of cash to tide them over while their latest drugs and technologies are in trial and developmental stages.
Read More
from
MoneyShow.com
Oncolytics (ONCY) Completes Enrollment in U.K. REOLYSIN Study
February 23, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6316396 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Meets Primary Endpoint in Phase 2 Trial of REOLYSIN Early
February 14, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6287783 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics (ONCY) meets primary endpoint for first part of US Phase 2 pancreatic cancer clinical trial
February 14, 2011
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6287770 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Commences Enrollment in Paclitaxel with REOLYSIN Phase II
December 01, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6135511 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Announces Publishing of Reovirus and Docetaxel Paper in Patients with Advanced Cancer
November 29, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6130248 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Announces COG to Conduct REOLYSIN Phase 1 in Combo with Cyclophosphamide
November 18, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6116497 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Posts Narrower than Expected Q3 Loss of $0.07 Per Share
November 10, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6092568 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Reports Interim Data from REOLYSIN REO 013 Trial
October 26, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6052118 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE 1-Oncolytics shares rise on cancer-related patent
September 28, 2010
TORONTO, Sept 28 (Reuters) - Shares of Oncolytics Biotech Inc jumped more than 12 percent on Tuesday after it announced it had received approval for a U.S. patent relating to its research on cancer...
Read More
category
companyNews
from
Reuters: Company News
Oncolytics Biotech (ONCY) Awarded U.S. Patent for Modified Reovirus Creation Methods
September 28, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=6000400 for the full story.
Read More
from
StreetInsider.com News Articles
UPDATE 1-Oncolytics stock rises on cancer study approval
September 02, 2010
* Mid-stage ovarian cancer study using Reolysin approved
Read More
category
companyNews
from
Reuters: Company News
Oncolytics Biotech (ONCY) Announces the GOG Will Initiate REOLYSIN Phase II
September 02, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5941206 for the full story.
Read More
from
StreetInsider.com News Articles
Bridgewater Systems and Oncolytics Biotech Inc. Under Current Evaluation
August 13, 2010
from
ACCESSWIRE
Picking Low-Priced Stocks Using Volume
August 12, 2010
One of few positives from the great bear market is that there are now many stocks from established companies that are still trading below $10, even one year after the March lows.
Read More
from
MoneyShow.com
Oncolytics Biotech (ONCY) Gets No Objection Letter to Commence REOLYSIN Phase 3
July 19, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5813781 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Gets U.S. Patent for Treating Cell Proliferative Disorders
June 17, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5738053 for the full story.
Read More
from
StreetInsider.com News Articles
Canaccord Genuity Maintains a 'Buy' Rating on Oncolytics Biotech (ONCY); Intriguing Overall Survival Data at ASCO
June 08, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5711249 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Presents Data from REOLYSIN Phase I/II with Paclitaxel/Carboplatin
June 07, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5706237 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics (ONCY) Receives Approval from Belgium FAMHP to Conduct Phase 3 Trial for REOLYSIN
June 01, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5687303 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Starts REOLYSIN Phase 2 Enrollment
May 26, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5674946 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Commences Enrollment in REOLYSIN Phase 3
May 25, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5670809 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) To Present Abstracts for REOLYSIN at ASCO 2010 Annual Meeting
May 21, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5662457 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Initiates REOLYSIN Phase I with FOLFIRI
May 19, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5653398 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech, Inc. (ONCY) Posts Q1 Loss of $0.07, Narrower than Views
May 12, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5624857 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Completes Enrollment in REOLYSIN Phase I/II
April 23, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5556840 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech (ONCY) Updates on Reovirus Abstracts and Preclinical Research
April 14, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5527721 for the full story.
Read More
from
StreetInsider.com News Articles
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Gets A Possitve Feedback
April 09, 2010
Oncolytics Biotech, Inc. ( NASDAQ:ONCY ) was picked up by a couple stock newsletters as they pointed out a scientific publication discussing synergistic effects of anti-cancer drugs. Momentum traders...
Read More
category
Stocks
from
Hotstocked.com articles
Oncolytics Biotech (ONCY) Announces Publication of Paper Regarding Antiandiogenic Cancer Therapy in Combination with Oncolytic Virotherapy
April 08, 2010
Visit StreetInsider.com at http://www.streetinsider.com/news.php?st=p&id=5513387 for the full story.
Read More
from
StreetInsider.com News Articles
< Previous
1
2
3
4
5
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here